Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
BofA Securities Maintains Evotec(EVO.US) With Sell Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)
U.S. Job Cuts Jump 38% in April, While Year-to-date Total Drops 50%: Challenger Job Cuts Report
TD Cowen Maintains Evotec(EVO.US) With Buy Rating, Maintains Target Price $4
TD Cowen Remains a Buy on Evotec AG (EVO)
Earnings Scheduled For May 6, 2026